What are the treatments for Meniere's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatments for Meniere's Disease

The treatment of Meniere's disease follows a stepwise approach, beginning with lifestyle modifications and medical management, progressing to intratympanic therapies, and finally to surgical interventions when conservative measures fail. 1

First-Line Treatments: Lifestyle Modifications

  • Low-sodium diet (1500-2300 mg daily) is recommended to reduce endolymphatic pressure and symptom frequency 1, 2
  • Limit alcohol and caffeine intake to reduce trigger factors 1, 2
  • Stress management techniques to minimize attack triggers 1
  • Allergy management when relevant 1
  • Adequate sleep and exercise to improve overall symptom control 1
  • Support groups to help with psychological aspects of the disease 1

Medical Management

Acute Attack Management

  • Vestibular suppressants (benzodiazepines, anticholinergics) should be used ONLY during acute attacks due to risk of dependence 1
  • Antiemetics to control nausea and vomiting during attacks 1
  • Antihistamines may provide symptomatic relief 1

⚠️ Caution: Prolonged use of vestibular suppressants delays central compensation and should be strictly limited to acute attacks 1

Preventive Medications

  • Diuretics (thiazides, potassium-sparing diuretics, loop diuretics, carbonic anhydrase inhibitors) to reduce endolymph volume 1
  • Betahistine (16-48 mg daily in divided doses) - commonly used in Europe and recommended by international consensus 1, 3
    • Use with caution in patients with asthma or peptic ulcer disease
    • Avoid in patients with pheochromocytoma
    • Note: Recent high-quality trials show mixed efficacy results 1
  • Local pressure therapy (Meniett device) - though systematic reviews show no significant difference compared to placebo 1, 3

Second-Line Treatment

  • Intratympanic steroid injections when first-line treatments fail 1, 3
    • Benefits: Improved vertigo control, quality of life, faster return to work
    • Risks: Eardrum perforation, persistent imbalance

Third-Line Treatments (Based on Hearing Status)

For Patients with Serviceable Hearing

  • Endolymphatic sac decompression surgery to reduce endolymphatic pressure 1, 3
  • Vestibular rehabilitation/physical therapy for chronic imbalance between attacks (not during acute episodes) 1

For Patients with Poor Hearing

  • Intratympanic gentamicin to reduce vestibular function in the affected ear 1, 3, 4
    • Modern low-dose protocols aim to control vertigo while minimizing hearing loss risk
    • Most effective for persistent vertigo despite medical management

Last-Resort Surgical Options

  • Vestibular nerve section for patients with serviceable hearing who have failed other treatments 1, 3
  • Labyrinthectomy for patients with non-serviceable hearing, controlling vertigo but sacrificing remaining hearing 1, 3
  • Cochlear implantation may be considered in conjunction with labyrinthectomy for profound hearing loss 3

Patient Education and Monitoring

  • Provide verbal and written information about the disease course and treatment options 1
  • Set realistic expectations (symptom management, not cure) 1
  • Regular audiologic and vestibular assessment to monitor disease progression 1
  • Consider hearing aids for patients with significant hearing loss 1

Treatment Algorithm

  1. Start with lifestyle modifications and dietary changes
  2. Add preventive medications (diuretics and/or betahistine)
  3. For persistent symptoms, proceed to intratympanic steroid injections
  4. If symptoms persist, choose based on hearing status:
    • Good hearing: Endolymphatic sac surgery
    • Poor hearing: Intratympanic gentamicin
  5. For refractory cases, consider destructive procedures based on hearing status

References

Guideline

Meniere's Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

International consensus (ICON) on treatment of Ménière's disease.

European annals of otorhinolaryngology, head and neck diseases, 2018

Research

Ménière's disease.

Current opinion in neurology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.